BioPlus Acquisition Corp. - G11217117
Sector:
Healthcare
· Industry:
Electromedical & Electrotherapeutic Apparatus
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q3 2023
· Q2 2023
Value (USD)
Total reported value ($000)
$50.37M
QoQ value delta ($000)
-$3.252M
(-6.06%)
Implied price effect (QoQ)
+1.69%
Shares
Total shares
4,649,861
QoQ shares delta
-383,680
(-7.62%)
Total shares held by funds (by quarter)
Top holders (Q3 2023)
Top 25 only
Full list
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| LINDEN ADVISORS LP | 10,830 | 1,000,000 | 0.11% |
| WOLVERINE ASSET MANAGEMENT LLC | 5,646 | 520,910 | 0.06% |
| AQR Arbitrage LLC | 5,230 | 482,993 | 0.23% |
| Hudson Bay Capital Management LP | 4,873 | 450,000 | 0.04% |
| Centiva Capital, LP | 4,623 | 426,937 | 0.1% |
| Walleye Capital LLC | 4,050 | 373,682 | 0.01% |
| Polar Asset Management Partners Inc. | 3,685 | 340,000 | 0.08% |
| Saba Capital Management, L.P. | 3,502 | 323,142 | 0.08% |
| ARISTEIA CAPITAL LLC | 3,251 | 300,000 | 0.09% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 2,709 | 250,000 | 0.06% |
| Walleye Trading LLC | 1,974 | 182,197 | 0.01% |